Lithium : de nouvelles perspectives thérapeutiques ?

Albayrak, 2013, Protective effects of lithium: a new look at an old drug with potential antioxidative and anti-inflammatory effects in an animal model of sepsis, Int Immunopharmacol, 16, 35, 10.1016/j.intimp.2013.03.018 De Cristóbal, 2013, A longitudinal FDG-PET study of transgenic mice overexpressing GSK-3β in the brain, Curr Alzheimer Res Diniz, 2013, Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders, Neuropsychiatr Dis Treat, 9, 493, 10.2147/NDT.S33086 Forlenza, 2012, Does lithium prevent Alzheimer's disease?, Drugs Aging, 29, 335, 10.2165/11599180-000000000-00000 Forlenza, 2011, Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial, Br J Psychiatry J Ment Sci, 198, 351, 10.1192/bjp.bp.110.080044 Germaná, 2010, The effects of lithium and anticonvulsants on brain structure in bipolar disorder, Acta Psychiatr Scand, 122, 481, 10.1111/j.1600-0447.2010.01582.x Hampel, 2009, Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study, J Clin Psychiatry, 70, 922, 10.4088/JCP.08m04606 Hernandez, 2013, GSK3 and tau: two convergence points in Alzheimer's disease, J Alzheimers Dis JAD, 33, S141 Kessing, 2008, Lithium treatment and risk of dementia, Arch Gen Psychiatry, 65, 1331, 10.1001/archpsyc.65.11.1331 King, 2014, Glycogen synthase kinase-3 inhibitors: rescuers of cognitive impairments, Pharmacol Ther, 14, 1, 10.1016/j.pharmthera.2013.07.010 Lauterbach, 2011, Psychopharmacological neuroprotection in neurodegenerative diseases, part III: criteria-based assessment: a report of the ANPA committee on research, J Neuropsychiatry Clin Neurosci, 23, 242, 10.1176/appi.neuropsych.23.3.242 Leyhe, 2009, Increase of BDNF serum concentration in lithium treated patients with early Alzheimer's disease, J Alzheimers Dis JAD, 16, 649, 10.3233/JAD-2009-1004 Li, 2010, Lithium reduces apoptosis and autophagy after neonatal hypoxia-ischemia, Cell Death Dis, 1, e56, 10.1038/cddis.2010.33 Li, 2011, Lithium-mediated long-term neuroprotection in neonatal rat hypoxia-ischemia is associated with antiinflammatory effects and enhanced proliferation and survival of neural stem/progenitor cells, J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab, 31, 2106, 10.1038/jcbfm.2011.75 Nagahara, 2009, Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease, Nat Med, 15, 331, 10.1038/nm.1912 Nahman, 2012, Effects of lithium on lipopolysaccharide-induced inflammation in rat primary glia cells, Innate Immun, 18, 447, 10.1177/1753425911421512 Nunes, 2013, Microdose lithium treatment stabilized cognitive impairment in patients with Alzheimer's disease, Curr Alzheimer Res, 10, 104 Pasquali, 2010, Intracellular pathways underlying the effects of lithium, Behav Pharmacol, 21, 473, 10.1097/FBP.0b013e32833da5da Sarkar, 2005, Lithium induces autophagy by inhibiting inositol monophosphatase, J Cell Biol, 170, 1101, 10.1083/jcb.200504035 Shimada, 2012, Long-term oral lithium treatment attenuates motor disturbance in tauopathy model mice: Implications of autophagy promotion, Neurobiol Dis, 4, 101, 10.1016/j.nbd.2011.12.050 Sudduth, 2012, Lithium treatment of APPSwDI/NOS2-/- mice leads to reduced hyperphosphorylated tau, increased amyloid deposition and altered inflammatory phenotype, PLoS ONE, 7, e31993, 10.1371/journal.pone.0031993 Zhang, 2011, Long-term treatment with lithium alleviates memory deficits and reduces amyloid-β production in an aged Alzheimer's disease transgenic mouse model, J Alzheimers Dis JAD, 24, 739, 10.3233/JAD-2011-101875